Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2014  |  Volume : 10  |  Issue : 7  |  Page : 225--228

Tumor M2-pyruvate kinase in stool as a biomarker for diagnosis of colorectal cancer: A meta-analysis


Jin-Xi Huang1, Yi Zhou2, Cheng-Hu Wang4, Wei-Wei Yuan4, Zhan-dong Zhang4, Xie-Fu Zhang3 
1 Department of General Surgery, First Affiliated Hospital of Zhengzhou University, Henan Zhengzhou 450052; Department of General Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Zhengzhou 450003, China
2 Department of Anesthesiology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Zhengzhou 450003, China
3 Department of General Surgery, First Affiliated Hospital of Zhengzhou University, Henan Zhengzhou 450052, China

Correspondence Address:
Xie-Fu Zhang
Department of General Surgery, First Affiliated Hospital of Zhengzhou University, Henan Zhengzhou 450052
China

Objective: The aim of this meta-analysis was to evaluate the diagnosis value of tumor M2-pyruvate kinase (M2-PK) in stool as a biomarker for diagnosis of colorectal cancer. Materials and Methods: By searching the databases of Cochrane Library, PubMed, China national knowledge Information and Wanfang, the diagnosis study related to tumor M2-PK in stool as a biomarker for diagnosis of colorectal cancer were screened and included in this study. The pooled sensitivity, specificity, positive likelihood ratio (+LR), negative likelihood ratio (−LR) and the receiver operating characteristic curve (ROC) were calculated by stata 11.0 software. Results: According to the including criteria, 14 trials including 1990 subjects were finally included in this meta-analysis. The pooled diagnosis sensitivity, specificity, +LR, −LR and area under curve were 0.78 (95% confidence interval [CI]: 0.74-0.81), 0.77 (95% CI: 0.76-0.79), 4.38 (95% CI: 3.27-5.88), 0.28 (95% CI: 0.23-0.34) and 0.86 (95% CI: 0.834-0.89). No statistical publication bias was found in this study. Conclusion: Tumor M2-PK in stool can be a useful biomarker in the diagnosis of colorectal cancer with relative high sensitivity and specificity.


How to cite this article:
Huang JX, Zhou Y, Wang CH, Yuan WW, Zhang Zd, Zhang XF. Tumor M2-pyruvate kinase in stool as a biomarker for diagnosis of colorectal cancer: A meta-analysis.J Can Res Ther 2014;10:225-228


How to cite this URL:
Huang JX, Zhou Y, Wang CH, Yuan WW, Zhang Zd, Zhang XF. Tumor M2-pyruvate kinase in stool as a biomarker for diagnosis of colorectal cancer: A meta-analysis. J Can Res Ther [serial online] 2014 [cited 2022 May 17 ];10:225-228
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2014;volume=10;issue=7;spage=225;epage=228;aulast=Huang;type=0